InMode Ltd.(INMD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
INMD Stock Analysis & AI Quality Score
AI stock analysis and institutional research for InMode Ltd. (INMD), a Healthcare sector company. INMD is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), InMode Ltd. reports quarterly revenue of $370.5M, net income of $93.8M, an operating margin of 23.1%. Top institutional holders of INMD by reported 13-F value include Doma Perpetual Capital Management, RENAISSANCE TECHNOLOGIES, BlackRock,, based on the most recent SEC filings. INMD trades on the Nasdaq exchange and files with the SEC under CIK 1742692. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InMode Ltd. directly from SEC EDGAR.
Revenue
FY 2025
$370.5M
Net Income
FY 2025
$93.8M
Free Cash Flow
FY 2025
$84.3M
Operating Margin
FY 2025
23.1%
ROIC
FY 2025
12.5%
AI Insight: INMD Financial Trends
Insufficient granular data to assess operational trends; only equity balance shown across seven years.
• Equity declined from $704M in Q4 2024 to $683M in Q4 2025, a modest 3% contraction.
⚠ Revenue, profitability, cash flow, and debt figures absent from dataset; cannot evaluate core financial health.
AI Insight: INMD Ratio Trends
Insufficient data: all ratio fields are missing across the entire historical period.
• No operational, profitability, or return metrics available for analysis from Q4 2019 through Q4 2025.
⚠ Data completeness issue prevents assessment of margin trends, capital efficiency, or leverage evolution.
Get alerted when INMD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for InMode Ltd. including:
Top Institutional Holders of INMD
Doma Perpetual Capital Management LLC
$42.0M3,067,431 shRENAISSANCE TECHNOLOGIES LLC
$35.4M2,586,218 shBlackRock, Inc.
$30.8M2,254,729 shMENORA MIVTACHIM HOLDINGS LTD.
$27.9M2,040,000 shSTEEL PARTNERS HOLDINGS L.P.
$24.6M1,795,361 shMORGAN STANLEY
$18.1M1,323,783 shMILLENNIUM MANAGEMENT LLC
$15.9M1,161,780 shSYSTEMATIC FINANCIAL MANAGEMENT LP
$15.8M1,154,457 shGOLDMAN SACHS GROUP INC
$13.8M1,009,741 shJANUS HENDERSON GROUP PLC
$12.8M932,132 sh
| Fund | Value | Shares |
|---|---|---|
| Doma Perpetual Capital Management LLC | $42.0M | 3,067,431 |
| RENAISSANCE TECHNOLOGIES LLC | $35.4M | 2,586,218 |
| BlackRock, Inc. | $30.8M | 2,254,729 |
| MENORA MIVTACHIM HOLDINGS LTD. | $27.9M | 2,040,000 |
| STEEL PARTNERS HOLDINGS L.P. | $24.6M | 1,795,361 |
| MORGAN STANLEY | $18.1M | 1,323,783 |
| MILLENNIUM MANAGEMENT LLC | $15.9M | 1,161,780 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $15.8M | 1,154,457 |
| GOLDMAN SACHS GROUP INC | $13.8M | 1,009,741 |
| JANUS HENDERSON GROUP PLC | $12.8M | 932,132 |
More Healthcare Companies
View all Healthcare →Put INMD on your watchlist
Track score changes the day InMode Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INMD a good stock to buy?
13F Pro's AI-powered analysis of InMode Ltd. (INMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INMD are available on the INMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own INMD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InMode Ltd.'s investment landscape.